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Abstract
Background: In Denmark, approximately 12,000 hip and knee arthroplasties were performed in 2006,
and the hospital costs were close to US$ 110,000,000. In a randomized clinical trial, we have recently
demonstrated the efficacy of accelerated perioperative care and rehabilitation intervention after hip and
knee arthroplasty compared to current intervention under ideal circumstances. We do not, however,
know whether these results could be reached under usual circumstances of healthcare practice. We
therefore investigated whether length of stay after implementation of accelerated perioperative care and
rehabilitation after hip and knee arthroplasty could be reduced in a normal healthcare setting, and how the
achieved results matched those observed during the randomized clinical trial.
Methods: An effectiveness study as a before-after trial was undertaken in which all elective primary total
hip and total knee arthroplasty patients were divided into a before-implementation group receiving the
current perioperative procedure, and an after-implementation group receiving the new accelerated
perioperative care and rehabilitation procedures as provided by a new multi-disciplinary organization. We
used the Breakthrough Series Collaborative Model for implementation. The primary outcome measure
was in hospital length of stay (LOS), and the secondary outcome measure was adverse effects within 3
months postoperatively.
Results: We included a total of 247 patients. Mean LOS was significantly (P < 0.001) reduced by 4.4 (95%
CI 3.8–5.0) days after implementation of the accelerated intervention, from 8.8 (SD 3.0) days before
implementation to 4.3 (SD 1.8) days after implementation. No significant differences in adverse effects
were observed. LOS in this effectiveness study was significantly lower than LOS reported in the efficacy
study.
Conclusion: Accelerated perioperative care and rehabilitation intervention after hip and knee
arthroplasty was successfully and effectively implemented. Results obtained during usual hospital
circumstances matched the results achieved under ideal circumstances in this group of patients.
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Total hip and knee arthroplasties are the surgical treat-
ments of choice when conservative treatments have failed
for incurable pain in the hip and knee, the leading cause
of which is osteoarthrosis [1]. In Denmark, the incidence
of hip arthroplasty was estimated to be 142 per 100,000
inhabitants, and the incidence of knee arthroplasty was
estimated to be 88 per 100,000 inhabitants in 2004 [2,3],
and both incidences are rising [3,4]. In 2006, approxi-
mately 12,000 hip and knee arthroplasties were per-
formed in Denmark [3]. In Denmark, the total hospital
costs for hip and knee arthroplasties were close to US$
110,000,000, based on the Danish diagnosis-related
group (DRG) tariffs for 2005 [5].
New procedures to optimize perioperative procedures, in
this study defined as procedures taking place in the period
from hospitalization to discharge, have been given several
different names, such as accelerated intervention, joint
recovery program, multi-disciplinary intervention, multi-
modal intervention, fast-track, and clinical pathway. The
concept of an accelerated postoperative recovery program
involves a coordinated effort to combine preoperative
education of patients, preoperative optimization, attenu-
ation of surgical stress response, optimized pain relief,
enforced mobilization, nutritional support, and up-to-
date postoperative nursing care and rehabilitation [6-9].
The concept of an accelerated postoperative recovery pro-
gram has been developed to reduce perioperative and
postoperative complications and to shorten the time
needed for full recovery, especially after major surgical
procedures [7]. In contrast, clinical pathways have been
implemented in the United States of America (USA) in an
effort to reduce length of hospital stay (LOS) and thereby
control the hospital costs, whereas less focus has been
placed on consequences for patients and society because
of the introduction of new accelerated interventions [10].
Great differences are reported in LOS after total hip
arthroplasty (THA), total knee arthroplasty (TKA), and
unicompartmental knee arthroplasty (UKA) between hos-
pitals in the USA and Europe [3,10]. Some of these differ-
ences could be explained by different motives for
implementation.
The British pioneer clinical epidemiologist Archie
Cochrane defined three concepts related to testing and
implementing new healthcare interventions. 1) Efficacy is
the extent to which an intervention does more good than
harm under ideal circumstances ("Can it work?"). Ideally,
the determination of efficacy is based on the results of a
randomized clinical trial (RCT) [11]. 2) Effectiveness
assesses whether an intervention does more good than
harm when provided under usual circumstances of
healthcare practice ("Does it work in practice?"). 3) Effi-
ciency measures the effect of an intervention in relation to
the resources it consumes ("Is it worth it?") [12]. Effi-
ciency trials are more often called cost-effectiveness. We
have followed this guideline, and have already demon-
strated efficacy of accelerated perioperative care and reha-
bilitation intervention after hip and knee arthroplasty,
and thereby answered the first of the three research ques-
tion [13]. We still need to investigate whether the new
accelerated intervention actually works under usual cir-
cumstances of healthcare practice.
Questions have been raised about the external validity of
results obtained in RCTs of fast-track programs in this
patient population because a large proportion of patients
do not participate in the interventional studies [13].
Another problem when extrapolating results from efficacy
studies to the target population is the Hawthorne effect
(positive effect of being under study) [11], which poten-
tially could affect both the healthcare staff and the
patients. We therefore investigated whether it was possi-
ble to reduce LOS after implementation of accelerated
perioperative care and rehabilitation intervention after
hip and knee arthroplasty, and how results obtained in an
effectiveness study corresponded to the results obtained
in an efficacy study.
Methods
Study design
The study design was an effectiveness study performed as
a prospective before-after trial. This clinical intervention
trial followed the recommendations of the CONSORT
Statement [14]. The study took place at the Orthopedic
Clinic at Regional Hospital Holstebro in Denmark
between January 2005 and April 2007. The procedures
followed in the study were in accordance with the ethical
standards of the responsible committee on human exper-
imentation and with the Helsinki Declaration of 1975, as
revised in 2000. The study protocol was approved by the
Medical Ethics Committee of Ringkoebing and Southern
Jutland Counties (Ref.:2627-04). The study was also regis-
tered in The Danish Data Protection Agency (J. no. 2004-
41-4753), and the Clinical Trial Register (NCT00175201).
Study subjects
All patients receiving a primary elective THA or TKA in the
Regional Hospital Holstebro in the two study periods
were consecutively included in the study. Patients receiv-
ing acute and revision surgery were excluded. Sample size
was calculated from an alpha set at 0.05, a beta set at 0.95,
average LOS estimated to be 8.0 days (SD 3.0) in the pre-
implementation period, and 6.5 days (SD 3.0) in the post-
implementation period. At least 104 patients were
therefore needed in both groups. For practical reasons, we
decided that the two study periods would be of equal
length, and we therefore included patients in the preim-
plementation period if they were operated on betweenPage 2 of 9
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period if they were operated on between September and
December 2006.
Organization and interventions concerning both groups
Organization
In the preimplementation period the ward consisted of 36
beds, and the healthcare staff of 47 persons. This was
reduced to 30 beds and a staff of 40 prior to our RCT [13],
which was 1 year prior to the postimplementation period.
The reduction in beds and staff did not affect patients
receiving arthroplasty. Five physiotherapists and one
occupational therapist managed rehabilitation. Approxi-
mately 20% of the ward, healthcare staff, and the rehabil-
itation staff were allocated to the arthroplasty patients.
The number of working days in the ward was not changed
during the study period. No unintentional change in staff-
to-patient ratio occurred during the study period.
Six experienced surgeons performed all operations during
the pre- and postimplementation period. The surgeons
each did an equal number of arthroplasties (Additional
file 1). Two surgeons, who did not perform THAs or TKAs
were together with the six surgeons solely responsible for
discharge. We took care that none of the organizational
changes during the study period affected discharge proce-
dures.
Intervention
Patients in both groups were subjected to identical opera-
tional procedures, defined as all procedures in the time-
frame from leaving the ward for surgery till they were back
in the ward after surgery. Operational procedures fol-
lowed Danish guidelines [15,16]. No changes in surgical
or anesthetic procedures from surgeons or anesthetists
took place during the entire study period. Therefore the
attenuation of the surgical stress response in both groups
of patients was identical. There were furthermore no
changes in post-discharge management.
Medication for pain relief was identical in the two groups.
We used a visual analog scale (VAS) to measure pain. A
VAS > 3 at rest and > 5 when active resulted in increased
dose in pain-relieving medication. Preoperatively, we
used paracetamol 1 mg. We used Oxycontin® on the day of
operation and the first day postoperatively. Doses were 10
mg 2 times daily for patients below 70 years of age, and
20 mg 2 times daily for patient at or above 70 years of age.
VAS > 3 triggered supplementary opioids. From the sec-
ond day postoperatively, we used Oxynorm® 5 mg if VAS
> 3. We did not use patient-controlled analgesia (PCA)
during the study period. We used Zofran® 4 mg for nausea
reduction. Likewise there was no difference in use of con-
tinuous passive motion (CPM) during the entire study
period, during which less than 2% of TKA patients used
CPM.
The areas investigated in our accelerated intervention were
therefore the changes in 1) the multi-disciplinary organi-
zation, and 2) the remaining elements from the multi-
modal intervention [6-9]: preoperative assessment and
information, optimization of oral nutrition from
increased protein and fluid consumption, early and
aggressive mobilization and exercise, hereafter defined as
accelerated perioperative care and rehabilitation interven-
tion.
Organization and intervention in preimplementation 
period
Patients were hospitalized the day before surgery, and
placed at random on the orthopedic ward. Patients were
admitted the day before surgery for operations planned
for Thursday to Friday, and on Friday if planned for Mon-
day. Hospitalization took place on all days from Monday
to Friday. A nutrition screening was performed on the day
of admission, and patients were given food according to
the result. The patients were given hospital garments to be
worn during the whole stay, informed of the overall plan,
and prepared for surgery. After surgery standard pain relief
and nausea control procedures, as described above, were
followed. The first day after surgery, the patients started
training in bed before lunch, and were mobilized out of
bed after lunch. After lunch, the patients were mobilized
for the first time by a physiotherapist. During the stay,
care was given in response to the patients' current needs.
During the stay, mobilization was increased and adjusted
according to the patients' immediate state in order to
reach the discharge criteria. On average the patients were
mobilized approximately 4 hours daily, starting with a
few hours daily and increasing day by day until discharge.
Mobilization consisted of all activities out of bed (50% of
mobilization time), gait training (25% of mobilization
time), and exercises (25% of mobilization time).
Organization and intervention in postimplementation 
period
Multi-disciplinary organization
Patients were placed in separate male and female beds in
the new nurse-lead multi-disciplinary accelerated care
unit, which was placed in a separate part of the ward.
Some intentional changes did occur in the organization.
Surgery took place in the beginning of the week. Some
nurse resources were moved from the end of the week to
the beginning of the week and some hours on Mondays
were moved from day to evening. All patients, accompa-
nied by one relative, were invited to an information and
preparation day the week before surgery. The purpose of
the information day was not only to inform patients
about the accelerated course of treatment, but also to pre-Page 3 of 9
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surgeon, anesthetist, and nurse. Final blood tests, ECG,
and radiographs were taken. Patients were hospitalized on
the day of surgery.
Multi-modal intervention
In order to avoid patients adopting a sick role, they wore
their own clothes during the whole stay. The healthcare
staff worked to achieve written preset daily goals regard-
ing: 1) information, 2) pain relief, 3) nausea control, 4)
nutrition, 5) mobilization, and 6) elimination. 1) Infor-
mation on the information day focused on goals during
the hospital stay and a planned discharge on the fourth
postoperative day if fulfillment of discharge criteria
(sooner than fourth day if fulfilled or later if not), how to
relieve pain, mobilization strategies, and providing them
with delivering walking aid and other remedies. 2) Stand-
ard pain relief. 3) Standard nausea control. 4) A nutrition
screening was performed on the information day, and
patients were given food according to the result in addi-
tion to a daily intake of two protein beverages and a total
fluid consumption of at least 1.5 liters. 5) Mobilization
started on the day of surgery. The first postoperative day,
the goal was 4 hours out of bed, including training with
physiotherapist and occupational therapist. We tried to
achieve more than 8 hours of mobilization per day for the
rest of the hospital stay. Mobilization consisted of all
activities out of bed (70% of mobilization time), gait
training (15% of mobilization time), and exercises (15%
of mobilization time). The physiotherapist was responsi-
ble for coaching the patient during exercises and gait train-
ing. Exercises focused on strengthening hip and knee
muscles and how to avoid restricted movements. The exer-
cises did not differ between the two intervention groups;
however, there was much more focus on intensity,
number of repetitions and progression in the accelerated
intervention group. The patients were taught how to
increase exercise and gait training after discharge. The
occupational therapist was responsible for instruction
regarding performance of personal needs for the THA
patients. All healthcare staff members were aware of using
all available situations for functional training, but also
that the patients got needed time for rest. 6) For elimina-
tion, we used Magnesia®. Patients likewise followed a
diary with the above-mentioned preset goals for nutrition,
fluid consumption, and mobilization.
For further detailed information regarding the accelerated
intervention, please see The Unit of Perioperative Nursing
Care (homepage on the Internet) [17].
Discharge in both groups
We used surgeons not otherwise involved in the study to
decide in agreement with patients when discharge criteria
were fulfilled. We tested the patients against the discharge
criteria once daily in the morning, and only when the
patient and the surgeons agreed on fulfillment of all crite-
ria was the patient prepared for discharge.
The discharge criteria were the same in all patients groups
during the whole study period except for the criteria of at
least 90° of knee flexion in knee patients, which was not
used in the postimplementation period. The discharge cri-
teria were: 1) acceptance of discharge, 2) sufficient pain
control, 3) aware of procedures for ending medication, 4)
knowing the restrictions, 5) being able to correctly rise
from lying and sitting 6) being able to walk safely with or
without walking aids, 7) if necessary, being able to walk
on stairs, 8) being able to perform home exercises, 9)
knowing how to increase home exercises, 10) being able
to perform personal needs, 11) helping aids delivered and
installed, and 12) surgical wound showing no signs of
infection 13) in knee patients, at least 90° of knee flexion
(in the preimplementation period).
Implementation method
We used the Breakthrough Series Collaborative Model,
which consists of preparation, project and spread phases
[18]. The spread phase to other wards and hospitals is cur-
rently ongoing, but is not reported in this study. We estab-
lished an implementation organization, enrolled
participants, and performed gradual implementation by
using three learning sessions, three action periods, and
three evaluation periods. Focus in all learning sessions
and action periods was to develop an effective multi-dis-
ciplinary organization which in a proactive manner could
master the multi-modal interventions [6-9]. After evalua-
tion of the second activity period, which was performed as
a RCT [19], the leading nurses who had developed the
program handed over the new multi-disciplinary organi-
zation plan to new leading personnel, who were put in
charge of the last full scale implementation in action
period 3. Moreover, most of the healthcare staff involved
in developing the new accelerated intervention was not
part of the new postimplementation staff.
Masking of healthcare staff and patients
The healthcare staffs in the pre- and postoperative periods
were not aware of the ongoing study because all data were
drawn from ongoing monitoring in the local and central
hospital registers [3]. Likewise the patients were not aware
of the ongoing study, because all contacts and question-
naires were part of the usual monitoring practice.
Outcome measures
Primary outcome was in hospital LOS from admission to
discharge. Secondary outcome measures were adverse
effects (major perioperative complications, readmission
within 30 days, and mortality within 3 months postoper-
atively). Data on all patients were collected via personalPage 4 of 9
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complications in these patients were sought in all Danish
local and central hospital registers, which are available in
closed databases.
Statistics
The primary analysis was to test the difference in LOS
between the current intervention observed in the preim-
plementation period and the fully implemented acceler-
ated intervention in the postimplementation period. This
analysis represents the effectiveness analysis of the accel-
erated intervention. Secondary analysis was to test the dif-
ference in LOS reported in the accelerated intervention
group in the RCT by Larsen et al. [19] ("best case") with
LOS obtained in the fully implemented procedures in the
postimplementation period ("real case"), to see whether
effectiveness could match efficacy. In addition, our goal
was to test the difference between LOS obtained in the
current intervention group in the preimplementation
period (non-awareness of being under study) with LOS
reported in the RCT by Larsen et al. [19] (awareness of
ongoing study). LOS is presented with mean and standard
deviation, together with the median and range. Because of
the expectation of a non-normal distribution of LOS, the
differences between groups were tested using Mann-Whit-
ney rank sum test in the unadjusted analysis. In the mul-
tivariate analysis we used the non-parametric percentile
method after a multivariate linear regression with 2000
non-parametric bootstrap replicates. The 95% confidence
intervals were retrieved from 2000 bias-corrected and
accelerated bootstrap replicates. A bootstrap simulation is
a non-parametric method in which a random sample of
the same size as the original sample is drawn several times
with replacement from the original data. The differences
in LOS were adjusted for gender, age, diagnosis, implant
type, and patient group (THA, TKA). Categorical data were
analyzed with Fisher's Exact test. The significance level
was set at P < 0.05.
Results
Patient characteristics
A total of 105 patients were included in the preimplemen-
tation period, of which 15 were admitted on a Friday, and
142 patients were included in the postimplementation
period. Complete data from all 247 patients receiving
THAs and TKAs in the orthopedic clinic at the Regional
Hospital Holstebro were available from admission to 3-
month follow-up (Figure 1). Patient characteristic are pre-
sented in Additional file 1. No significant differences in
patient characteristic between the two groups were
observed. All patients met the discharge criteria before dis-
charge.
Length of stay
We observed a crude adjusted average reduction in LOS of
4.4 days (95% CI 3.8 – 5.0) from a LOS of 8.8 days (SD
3.0) for all patients receiving the current procedure in the
preimplementation period to 4.3 days (SD 1.8) for all
patients receiving the fully implemented accelerated inter-
vention in the postimplementation period (P < 0.001).
Mean LOS for the 15 patients admitted on a Friday was
9.8 days (SD 2.6), and mean LOS for the 90 patients
admitted the day before surgery was 8.6 days (SD 3.0).
The crude adjusted average reduction in LOS when
excluding the 15 patients admitted on a Friday was 4.2
days (95% CI 3.7 – 4.9) (P < 0.001). Mean postoperative
LOS (excluding LOS prior to the day of surgery) for the
105 patients in the preimplementation period was 7.5
days (SD 3.0). The crude adjusted average reduction in
postoperative LOS was 3.1 days (95% CI 2.6 – 3.7) (P <
0.001). Crude LOS in the postimplementation period for
the patients receiving the accelerated intervention was
reduced to 4.0 days (SD 1.7) for the THA patients and 4.7
days (SD 1.7) for the TKA patients. For further informa-
tion on unadjusted and adjusted crude and stratified
results for LOS please refer to Additional file 2.
Crude LOS in the accelerated intervention group in the
efficacy study by Larsen et al. was 5.0 (SD 2.4) (THA 4.3
(SD, 1.3), TKA 6.1 (SD, 3.5)) [19]. Compared to that
result, we observed a significant further reduction in
adjusted crude LOS of 0.8 (95% CI, 0.2 – 1.7), favoring
the postimplementation period (P = 0.031).
Flowchart of patients in effectiveness studyigure 1
Flowchart of patients in effectiveness study.Page 5 of 9
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the efficacy study by Larsen et al., in which the healthcare
staff and patients were aware of the ongoing study, was
7.8 (SD 2.1) (THA 7.3 (SD, 1.5), TKA 9.3 (SD, 2.5)) [19].
Compared to that result, we observed a significantly
longer adjusted LOS of 0.3 (95% CI 0.1–0.5) in the cur-
rent intervention group in the preimplementation period,
in which the healthcare staff and patient were not aware
of the ongoing study (P = 0.015).
Adverse effects
We registered only one major perioperative complication
related to the implant in a THA patient in the postimple-
mentation period. This complication, however, did not
lead to a prolonged LOS.
No significant difference in number of patients readmit-
ted within 30 days was observed. Five of 63 THA patients
were readmitted in the preimplementation group, and 3
of 76 THA patients were readmitted in the postimplemen-
tation group (P = 0.472). Only 1 of 42 TKA patients was
readmitted in the preimplementation group, versus of 3
out of 66 TKA patients in the postimplementation group
(P = 1.0).
Likewise, no significant difference in mortality was
observed, as only one patient in the preimplementation
group, a 50-year old female THA patient, died periopera-
tively because of a respiratory arrest after pneumonia, and
only one patient in the postimplementation group, a 85-
year old female TKA patient, died 5 weeks after discharge,
likewise after pneumonia (P = 1.0).
Discussion
Our study revealed the successful implementation of
accelerated perioperative care and rehabilitation interven-
tion after hip and knee arthroplasty. We have further doc-
umented that LOS could be markedly reduced without
increasing mortality and morbidity. Finally, we have doc-
umented that effectiveness could actually match efficacy
in this patient population.
We believe that the observed reduction in adjusted LOS of
4.4 days between the preimplementation period and the
postimplementation period was achieved by contribution
from both parts of our accelerated intervention (i.e.
changes in multi-disciplinary organization and multi-
modal intervention). The change in admission procedure
required the introduction of an information day, and was
successfully implemented, although it was a great chal-
lenge and involved many departments. The new nurse-
lead organization was the main factor responsible for the
satisfactory function of the multi-disciplinary organiza-
tion and acted in a more proactive manner than in previ-
ous systems because of clearly defined tasks and
responsibility.
We believe the elements from the multi-modal interven-
tion that contributed the most to the favorable results
were the information day and the early and more aggres-
sive mobilization, because there were no differences in
operational procedures between the two intervention
groups and only minor differences regarding pain relief,
nausea reduction, nutrition and elimination.
When we compared the results from our efficacy study
with the results from our effectiveness study, we expected
that the average LOS in the accelerated intervention group
in the efficacy would study to be shorter than the LOS in
the postimplementation group in the effectiveness study
because a best-case scenario is thought to be better than a
real-case scenario. That the effectiveness result regarding
LOS was actually significantly shorter than that in the effi-
cacy study could have several explanations. One explana-
tion is that our efficacy study was actually a pragmatic
randomized clinical trial and a partial implementation
under relatively normal circumstances, and not a "labora-
tory setup". This may have impaired the ultimately achiev-
able result, which is therefore not known. We believe,
however, that most of the difference was because the
accelerated intervention was offered to all patients in the
effectiveness study, whereas a rather high proportion of
patients were not willing to participate in the efficacy
study. These non-participating patients consisted of at
least two different groups, one of which was a group of
younger patients receiving uncemented arthroplasties,
which we have shown to have the shortest LOS [19]. The
differences we observed between the results from the effi-
cacy and the effectiveness study could indicate that there
are problems in extrapolating results from RCTs with high
proportions of refusing patients to the target population.
This observation is in accordance with Petersen et al., who
along with others, have questioned the results from RCTs
with rather large proportions of non-participating
patients [13]. The difference in results between the two
study designs could not be explained by a mere extension
of the accelerated intervention from the efficacy to effec-
tiveness study, because all leading members of healthcare
staff and most other members of the other healthcare staff
differed between the two study periods.
When we compared the results obtained in the control
groups in the efficacy study and the effectiveness study,
there was some indication of a possible but small Haw-
thorne effect in the efficacy study, because we had ruled
out contamination in the control group in the efficacy
study by a structured observation [19]. The result for LOS
in the control group in the efficacy study, in which
patients and healthcare staff were aware of being underPage 6 of 9
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tives of the study, was significantly lower than that
observed in the effectiveness study, in which they were not
aware of being under study [19]. This observation is in
line with the results presented in the RCT by Dowsey et al.,
in which they reported a large reduction in LOS in both
the intervention and control groups compared to the
period just prior to the study period [20]. The Hawthorne
effect could potentially have been even larger because we
would have expected a small increase in LOS in the con-
trol group in the RCT because of a higher proportion of
patients admitted on Fridays, because surgery in this
period was done at the beginning of the week.
The observed reduction in LOS from preimplementation
period to postimplementation period in our study is in
accordance with three of the four published efficacy stud-
ies [19-21], but in conflict with the study by Petersen et. al
[22]. The result is also in accordance with other Danish
effectiveness studies [23-27]. It also corresponds well with
the results reported in the review by Kim et al. [28] and in
the Dutch cost-effectiveness study by Brunenberg et al.
[29]
The observed number of complications is also in accord-
ance with a comparable publication, in which a tendency
towards fewer complications for hip patients and more
complications for knee patients is reported [30].
Have we reached the limit with our implementation
regarding LOS after accelerated procedures for hip and
knee arthroplasty? Apparently not, because the study by
Walter et al. indicates that it could be possible to further
accelerate the convalescence of these patient groups
because they reported an average LOS of 3.2 days for THA
patients and 3.0 for TKA patients by using a newly
designed clinical pathway [31]. But on moving from accel-
erated to super accelerated procedures, we have to be
extremely cautious because of serious early postoperative
complications [32]. Because an intervention aiming at
discharge within 3 days is not the same as an intervention
aiming at discharge within 7 days, we propose the follow-
ing definitions for future use in patients receiving primary
elective THA, TKA, and UKA: Super-accelerated interven-
tion is defined as an intervention with planned discharge
within 3 days. Accelerated intervention is defined as an
intervention with planned discharge within 5 days. Semi-
accelerated intervention is defined as an intervention with
planned discharge within 7 days. Non-accelerated inter-
vention is defined as an intervention with an average LOS
of more than 7 days. These definitions are in line with the
definition used in the Danish Health Technology Assess-
ment for THA and TKA [30].
We consider the quality of our data to be good, since all
data used were obtained from available official Danish
databases, which have been in use for several years and
been through some form of validation process [33]. We
also searched data from all Danish hospitals in order not
to miss patients readmitted to hospitals outside our own
region.
We observed a reduction in beds and healthcare staff from
preimplementation period to postimplementation
period, which potentially could have affected the results
through pressure on change in discharge procedures.
However, the reduction in beds and staff did not concern
arthroplasty patients, and we do not believe that it had
any effect on discharge because the concerned healthcare
staff was not involved in discharge, which was performed
by surgeons not otherwise involved in the study.
Identical discharge criteria were a core principle in this
study because LOS was both related to intervention and
outcome. We did, however, omit the criterion of at least
90° of knee flexion in knee patients in the postimplemen-
tation period. This was done because we found that this
criterion was an unnecessary prerequisite for patients to
be mobilized and to function well in the RCT by Larsen et
al. [19]. Omission of this criterion is in accordance with
the Danish Health Technology Assessment for THA and
TKA [30]. We believe the omission of this criterion has led
to a reduction in LOS of approximately 1.5 days, because
LOS for TKA in our RCT [19], in which the intervention
was identical but the criterion was included had a LOS of
6.1 days, whereas LOS was 4.7 days in the postimplemen-
tation period, in which this criterion was omitted.
When we calculated LOS we used in hospital LOS from
admission to discharge, which is the actual time a patient
occupies a bed in the ward. The observed difference in
LOS therefore consisted of two elements, which we con-
sidered to be equally important parts of our accelerated
intervention, namely a reduction in LOS due to changed
admission procedures in the multi-disciplinary organiza-
tion, and a reduction in LOS due to changed multi-modal
intervention. It was not the purpose of this study to distin-
guish between these two elements. But in our RCT, we
observed a reduction in LOS because of a change in the
organization of admission procedures to account for a
mean reduction of 1.5 days [19], and we have shown that
this result also applies to this study.
When we estimated the reduction in LOS between groups,
we used multivariate analysis in order to adjust for poten-
tial differences in the most important covariates to get the
most precise estimate. In our multivariate analysis the dif-
ferences in LOS were adjusted for gender, age, diagnosis,
implant type, and patient group (THA, TKA), which arePage 7 of 9
(page number not for citation purposes)
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case mix [34,35]. Other relevant patient characteristics are
American Society of Anaesthesiology Score (ASA) and
blood transfusion [36]. However, we were not able to
include ASA scores because of invalid and incomplete
data, and did not include blood transfusion because the
operational procedure was not part of the intervention.
Costs and consequences for other healthcare sectors
owing to changes in interventions in the hospital are
indeed relevant, and these questions will be answered in
ongoing cost-efficacy and cost-effectiveness studies.
It is, however, a limitation of the current study that there
were no patient-reported outcome data or functional per-
formance tests. We intended to include the patient-spe-
cific outcome measures, which are reported to the Danish
Hip and Knee Arthroplasty registers, but we found these
data to be invalid and incomplete. We do, however, know
from our own RCT, that TKA patients reports equal
health-related quality-of-life (HRQOL) 3 months postop-
eratively, irrespective of receiving standard or accelerated
interventions, while THA patients receiving accelerated
intervention report a HRQOL 3 months postoperatively
that is approximately 10% higher that patients receiving
the non-accelerated intervention [19]. We are currently
performing a study in which we investigate whether this
observation regarding HRQOL observed in our RCT also
applies when we compare the preimplementation period
with the postimplementation period.
In summary, we still need to evaluate results from efficacy,
effectiveness, and efficiency studies before accepting a
new program of intervention. Special care must though be
taken in the future to minimize the proportion of non-
participating patients in efficacy studies, because we could
miss the ultimately achievable results. We must include
information on as many potential confounders as possi-
ble in effectiveness studies in order to reduce bias, and we
must also investigate the costs and consequences outside
the hospital due to changes in hospital interventions.
Conclusion
Accelerated perioperative care and rehabilitation interven-
tion after hip and knee arthroplasty was successfully and
effectively implemented. Results obtained during usual
hospital circumstances matched the results achieved
under ideal circumstances in this group of patients.
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